Franklin Resources’s Yarrow Bioscience YARW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-107
Closed -$14.4K 2399
2022
Q4
$14.4K Hold
107
﹤0.01% 2290
2022
Q3
$21K Hold
107
﹤0.01% 2254
2022
Q2
$37K Sell
107
-51
-32% -$21.4K ﹤0.01% 2274
2022
Q1
$93K Hold
158
﹤0.01% 2308
2021
Q4
$145K Sell
158
-1,977
-93% -$2.12M ﹤0.01% 2290
2021
Q3
$2.67M Buy
2,135
+23
+1% +$44.6K ﹤0.01% 1380
2021
Q2
$6.67M Buy
2,112
+235
+13% +$930K ﹤0.01% 1077
2021
Q1
$11.6M Hold
1,877
﹤0.01% 947
2020
Q4
$10.7M Hold
1,877
﹤0.01% 949
2020
Q3
$11.2M Hold
1,877
0.01% 883
2020
Q2
$11.7M Buy
+1,877
New +$12.7M 0.01% 838
2018
Q2
Sell
-56
Closed -$7.52M 1543
2018
Q1
$7.52M Buy
+56
New +$6.81M ﹤0.01% 977

Other funds holding YARW

Franklin Resources's YARW Position: Q1 2023 in Review

Franklin Resources sold out of Yarrow Bioscience (YARW) in Q1 2023, closing a stake of 107 shares — an estimated $14.4K sold.

Franklin Resources first reported a position in YARW in Q1 2018 and held it in 12 quarters. The position peaked at $11.7M in Q2 2020. 21 funds tracked by Wall St. Rank hold YARW as of Q1 2023.

  • Franklin Resources reported no remaining Yarrow Bioscience position as of Q1 2023 after selling out during the quarter.
  • Franklin Resources sold 107 Yarrow Bioscience shares in Q1 2023, an estimated $14.4K.
  • Franklin Resources first reported a position in Yarrow Bioscience in Q1 2018 and held it in 12 quarters.
  • Franklin Resources's Yarrow Bioscience position peaked at $11.7M in Q2 2020.
  • 21 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q1 2023.

Based on Franklin Resources's 13F filing for Q1 2023, filed 12 May 2023.